You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NIVO

Showing 1 - 25 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 13, 2022

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
Oct 31, 2022

Gastric Cancer, Chemo Effect Trial (Nivolumab plus SOX, Nivolumab, Gastrectomy)

Not yet recruiting
  • Gastric Cancer
  • Chemotherapy Effect
  • Nivolumab plus SOX
  • +2 more
  • (no location specified)
Jan 7, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)

Not yet recruiting
  • Immune-related Adverse Event
  • +3 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Dec 15, 2022

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

Suspended
  • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
  • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Melanoma Trial in Tampa (Tavo, Nivolumab, OncoSec Medical Electroporation Therapy System)

Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
May 31, 2022

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

NSCLC Trial in Durham (Nivolumab, Ipilimumab, Paclitaxel)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
Apr 22, 2022

Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)

Active, not recruiting
  • Refractory Central Nervous System Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    Jianmin Zhang
Jul 3, 2022

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

CNS B-Cell Non-Hodgkin Lymphoma, Recurrent CNS Lymphoma, Refractory CNS Lymphoma Trial in Houston (Ibrutinib, Nivolumab)

Recruiting
  • Central Nervous System B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Resectable Hepatocellular Carcinoma Trial in Houston (Nivolumab, Pegargiminase, Resection)

Recruiting
  • Resectable Hepatocellular Carcinoma
  • Nivolumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

Not yet recruiting
  • Pleural Biphasic Mesothelioma
  • Pleural Sarcomatoid Mesothelioma
  • Nivolumab
  • +5 more
  • (no location specified)
Dec 9, 2022

Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Sep 6, 2022

Gastrointestinal Stromal Tumor Trial in Los Angeles (Ipilimumab, Laboratory Biomarker Analysis, Nivolumab)

Completed
  • Gastrointestinal Stromal Tumor
  • Ipilimumab
  • +2 more
  • Los Angeles, California
    Rachel Andes
Aug 15, 2022

Metastatic Melanoma Trial in Lausanne (TIL, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Metastatic Melanoma
  • TIL
  • +4 more
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Oct 11, 2021

Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,

Not yet recruiting
  • Metastatic Prostate Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • VLP-encapsulated TLR9 Agonist CMP-001,
  • Nivolumab
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 26, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Chordoma Trial in Baltimore, New York (other, biological, radiation)

Active, not recruiting
  • Chordoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 3, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022